8ODR

Mimetic of UBC9-SUMO1

8ODR の概要

• エントリーDOI: 10.2210/pdb8odr/pdb
• 分子名称: SUMO-conjugating enzyme UBC9, Small ubiquitin-related modifier 1, SULFATE ION (3 entities in total)
• 機能のキーワード: ubc9, sumo1, conjugation, ubiquitin-like, ligase
• 由来する生物種: Homo sapiens (human); 詳細
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 29575.74

構造登録者

Coste, F.,Goffinont, S.,Suskiewicz, M.J. (登録日: 2023-03-09, 公開日: 2023-06-07, 最終更新日: 2024-06-19)

主引用文献

Goffinont, S.,Coste, F.,Prieu-Serandon, P.,Mance, L.,Gaudon, V.,Garnier, N.,Castaing, B.,Suskiewicz, M.J.
Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
J.Biol.Chem., 299:104870-104870, 2023

PubMed Abstract: Protein SUMOylation is a ubiquitylation-like post-translational modification (PTM) that is synthesized through an enzymatic cascade involving an E1 (SAE1:SAE2), an E2 (UBC9), and various E3 enzymes. In the final step of this process, the small ubiquitin-like modifier (SUMO) is transferred from the UBC9∼SUMO thioester onto a lysine residue of a protein substrate. This reaction can be accelerated by an E3 ligase. As the UBC9∼SUMO thioester is chemically unstable, a stable mimetic is desirable for structural studies of UBC9∼SUMO alone and in complex with a substrate and/or an E3 ligase. Recently, a strategy for generating a mimetic of the yeast E2∼SUMO thioester by mutating alanine 129 of Ubc9 to a lysine has been reported. Here, we reproduce and further investigate this approach using the human SUMOylation system and characterize the resulting mimetic of human UBC9∼SUMO1. We show that substituting lysine for alanine 129, but not for other active-site UBC9 residues, results in a UBC9 variant that is efficiently auto-SUMOylated. The auto-modification is dependent on cysteine 93 of UBC9, suggesting that it proceeds via this residue, through the same pathway as that for SUMOylation of substrates. The process is also partially dependent on aspartate 127 of UBC9 and accelerated by high pH, highlighting the importance of the substrate lysine protonation state for efficient SUMOylation. Finally, we present the crystal structure of the UBC9-SUMO1 molecule, which reveals the mimetic in an open conformation and its polymerization via the noncovalent SUMO-binding site on UBC9. Similar interactions could regulate UBC9∼SUMO in some cellular contexts.

PubMed: 37247759
DOI: 10.1016/j.jbc.2023.104870

実験手法

X-RAY DIFFRACTION (2.85 Å)